首页> Cancer medicine> Targeting Tumorigenic Coactivators in the PI3K/AKT Signaling Pathway: A Novel Approach for Cancer Treatment.

Targeting Tumorigenic Coactivators in the PI3K/AKT Signaling Pathway: A Novel Approach for Cancer Treatment.

导出 LinkOut

翻译打印收藏纠错

第一作者： Md Anwarul,Haque

第一单位： Department of Pharmacy, Faculty of Science, University of Rajshahi, Rajshahi, Bangladesh.;Department of Experimental Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

作者： Md Anwarul,Haque ^[1] ; Thanasis,Poullikkas ^[2] ; F M Al-Amin,Kaisar ^[3] ; Alam,Khan ^[3] ; Shariful,Haque ^[4] ; Murshida,Mollik ^[5] ; Mst Jannatul,Mowa ^[3] ; Mst Hajera,Khatun ^[6] ; Al,Mamun ^[3] ; Mst Boby Aktar,Bithy ^[5]

作者单位： Department of Pharmacy, Faculty of Science, University of Rajshahi, Rajshahi, Bangladesh.;Department of Experimental Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. ^[1] Department of Experimental Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.;Department of Biochemistry and Systems Biomedicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.;Nakatani Biomedical Spatialomics Hub, Juntendo University Graduate School of Medicine, Tokyo, Japan. ^[2] Department of Pharmacy, Faculty of Science, University of Rajshahi, Rajshahi, Bangladesh. ^[3] Department of Pharmacy, Pabna University of Science and Technology, Pabna, Bangladesh. ^[4] Department of Pharmacy, Manarat International University, Dhaka, Bangladesh. ^[5] Department of Pharmacy, School of Science and Technology, Varendra University, Rajshahi, Bangladesh. ^[6]

关键词 PI3K/AKT signaling SALL4 TCL1B TGF‐β TMEPAI